Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$313.71 USD
-2.06 (-0.65%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $313.75 +0.04 (0.01%) 5:50 PM ET
5-Strong Sell of 5 5
A Value F Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Elevance Health, Inc. has a PEG ratio of 1.05 compared to the Medical Services industry's PEG ratio of 1.52.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ELV 313.71 -2.06(-0.65%)
Will ELV be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ELV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELV
CVS Health Steps Up to Bolster Oak Street as Cost Pressures Mount
Arista Networks and Elevance Health have been highlighted as Zacks Bull and Bear of the Day
ELV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bear of the Day: Elevance Health (ELV)
New Strong Sell Stocks for September 15th
Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?
Other News for ELV
ELV Crossed Above 20 Day Moving Average on September 18
Tracking William Nygren's Harris Associates Portfolio - Q2 2025 Update
20 Day Moving Average Resistance appears for ELV after 0.49% move
Obamacare tax credits could expand budget deficit by $350B if extended, CBO says
U.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meeting